These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis. Levstik A; Stuart A; Adams PC Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525 [TBL] [Abstract][Full Text] [Related]
5. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload. McLaren CE; Emond MJ; Subramaniam VN; Phatak PD; Barton JC; Adams PC; Goh JB; McDonald CJ; Powell LW; Gurrin LC; Allen KJ; Nickerson DA; Louie T; Ramm GA; Anderson GJ; McLaren GD Hepatology; 2015 Aug; 62(2):429-39. PubMed ID: 25605615 [TBL] [Abstract][Full Text] [Related]
6. The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda. Farrell CP; Overbey JR; Naik H; Nance D; McLaren GD; McLaren CE; Zhou L; Desnick RJ; Parker CJ; Phillips JD PLoS One; 2016; 11(9):e0163322. PubMed ID: 27661980 [TBL] [Abstract][Full Text] [Related]
7. Gnpat does not play an essential role in systemic iron homeostasis in murine model. An P; Wang J; Wang H; Jiang L; Wang J; Min J; Wang F J Cell Mol Med; 2020 Apr; 24(7):4118-4126. PubMed ID: 32108988 [TBL] [Abstract][Full Text] [Related]
8. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors. Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416 [TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y. Barton JC; Barton JC; Acton RT BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679 [TBL] [Abstract][Full Text] [Related]
10. Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y. Barton JC; Barton JC; Acton RT PLoS One; 2022; 17(7):e0271973. PubMed ID: 35895739 [TBL] [Abstract][Full Text] [Related]
11. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Gordeuk VR; Reboussin DM; McLaren CE; Barton JC; Acton RT; McLaren GD; Harris EL; Reiss JA; Adams PC; Speechley M; Phatak PD; Sholinsky P; Eckfeldt JH; Chen WP; Passmore L; Dawkins FW Am J Hematol; 2008 Aug; 83(8):618-26. PubMed ID: 18429050 [TBL] [Abstract][Full Text] [Related]
12. Ethnic and genetic factors of iron status in women of reproductive age. Gordeuk VR; Brannon PM Am J Clin Nutr; 2017 Dec; 106(Suppl 6):1594S-1599S. PubMed ID: 29070555 [No Abstract] [Full Text] [Related]
13. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O; Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476 [TBL] [Abstract][Full Text] [Related]
14. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity. Barton JC; Barton JC; Acton RT Hereditas; 2022 Jun; 159(1):25. PubMed ID: 35659379 [TBL] [Abstract][Full Text] [Related]
15. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997 [TBL] [Abstract][Full Text] [Related]
16. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Barton JC; Wiener HW; Acton RT; Go RC Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698 [TBL] [Abstract][Full Text] [Related]
17. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy. Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665 [TBL] [Abstract][Full Text] [Related]
18. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study. Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes. Barton JC; Barton JC; Adams PC Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361 [TBL] [Abstract][Full Text] [Related]
20. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women. Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC; J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]